Q4 2025 Seer Inc Earnings Call Transcript
Key Points
- Seer Inc (SEER) achieved a 17% year-over-year revenue growth in 2025, reaching $16.6 million.
- The company significantly expanded its installed base by 67%, ending the year with 82 instruments.
- Consumable kit volume increased by approximately 69%, indicating higher utilization of Seer Inc (SEER)'s technology.
- Seer Inc (SEER) launched its third-generation assay, Proteograph 1, and second-generation automation instrument, SP 200, enhancing proteomic depth and scalability.
- The company ended 2025 with a strong balance sheet, holding approximately $241 million in cash equivalents and investments.
- Seer Inc (SEER) faced ongoing budgetary pressures, including uncertainty around NIH funding, impacting customer spending decisions.
- The company's fourth-quarter revenue fell short of expectations due to delayed NIH funding and cautious customer spending.
- Despite growth, Seer Inc (SEER) reported a net loss of $73.6 million for the full year 2025.
- The company anticipates continued pressure on instrument placements and new project funding in 2026 due to an uncertain funding environment.
- Seer Inc (SEER) experienced elongated sales cycles and pressure on CapEx budgets, affecting outright purchases of new instruments.
Good day and welcome to the SEE 4th quarter 2025 earnings conference call.
Today, all participants will be in a listen-only mode. Should you need assistance during today's call, please signal for a conference specialist by pressing the star key followed by zero.
After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press 1 on your telephone keypad. To, withdraw your question, please press, then 2.
Please note that today's event is being recorded. I would now like to turn the conference over to Kelly Gurra, Investor relations. Please go ahead.
Thank you. Earlier today, SER released financial results for the quarter and the year ended December 31, 2025. If you've not received this news release, or if you'd like to be added to the company's distribution list, please send an email to [email protected].
In addition, during today's conference call, we will be referencing a slide presentation that can be accessed on the events
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
